HOME › DRUGS › TISAGENLECLEUCEL
ACTIVE SUBSTANCE / INN

TISAGENLECLEUCEL

Brand name(s): Kymriah
EMA LISTED
AUTHORISED
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, L…
ACTIVE SUBSTANCE
Tisagenlecleucel
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KymriahNovartis Europharm LimitedAuthorised23/08/2018Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse

FULL INTELLIGENCE ON TISAGENLECLEUCEL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →